Glaukos Corporation (GKOS)
NYSE · Healthcare
Glaukos Corporation EBITDA 2013–2025
Glaukos Corporation annual/quarterly ebitda history and growth rate from 2013 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Glaukos Corporation ebitda for the quarter ending March 31, 2026 was -8.1 M, a 35.27% decrease year-over-year.
- Glaukos Corporation ebitda for the twelve months ending March 31, 2026 was -39.5 M, a 39.56% decrease year-over-year.
- Glaukos Corporation annual ebitda for 2025 was -161.5 M, a 86.25% increase from 2024.
- Glaukos Corporation annual ebitda for 2024 was -86.7 M, a 8.76% decrease from 2023.
- Glaukos Corporation annual ebitda for 2023 was -95.0 M, a 87.33% increase from 2022.
- Glaukos Corporation annual ebitda for 2022 was -50.7 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Glaukos Corporation EBITDA — FAQ
Glaukos Corporation (GKOS) ebitda over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GKOS's ebitda history?
The chart and table above show Glaukos Corporation's ebitda by year and by quarter, including the growth rate.